Information  X 
Enter a valid email address

BBGI SICAV S.A (BBGI)

  Print      Mail a friend

Friday 29 June, 2018

BBGI SICAV S.A

Total Voting Rights

RNS Number : 1481T
BBGI SICAV S.A.
29 June 2018
 

29 June 2018

 

BBGI SICAV S.A.

(the "Company")

 

Total Voting Rights Update

 

In compliance with the Disclosure Guidance and Transparency Rules (DTR 5.6.1) BBGI SICAV S.A. (LSE ticker: BBGI), the global PPP infrastructure investment company, confirms that, as at 29 June 2018, the Company had issued share capital consisting of 529,189,422 ordinary shares of no par value with voting rights. 

 

Accordingly, the total voting rights in respect of the Company were 529,189,422. Shareholders may use this figure as the denominator for the calculations by which they determine whether they are required to notify their interest, or a change to their interest, in the Company.

 

 

For further information, please contact:

 

BBGI Management Team        +352 263 479 1

Duncan Ball

Frank Schramm

 

 

BBGI owns a global portfolio of 44 infrastructure assets. These are PPP assets and are supported by contracted, public sector-backed revenue streams, with inflation-protection characteristics.

 

Further information about BBGI is available on its website at www.bb-gi.com *.

 

The Company's LEI is: 529900CV0RWCOP5YHK95

 

Any reference to the Company or BBGI refers also to its subsidiaries (where applicable).

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on its website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

                                                                  


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRSEFFMUFASEFM

a d v e r t i s e m e n t